4.7 Review

Current Status on Marine Products with Reversal Effect on Cancer Multidrug Resistance

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Eribulin mesylate: A novel halichondrin B analogue for the treatment of metastatic breast cancer

Ali McBride et al.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2012)

Review Biochemistry & Molecular Biology

Structural and Functional Properties of Human Multidrug Resistance Protein 1 (MRP1/ABCC1)

S. -M. He et al.

CURRENT MEDICINAL CHEMISTRY (2011)

Editorial Material Pharmacology & Pharmacy

Eribulin mesylate for the treatment of late-stage breast cancer

Carole Gourmelon et al.

EXPERT OPINION ON PHARMACOTHERAPY (2011)

Review Pharmacology & Pharmacy

The odyssey of marine pharmaceuticals: a current pipeline perspective

Alejandro M. S. Mayer et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2010)

Article Plant Sciences

Reversal of P-glycoprotein-mediated multidrug resistance by sipholane triterpenoids

Sandeep Jain et al.

JOURNAL OF NATURAL PRODUCTS (2007)

Review Biotechnology & Applied Microbiology

Targeting multidrug resistance in cancer

G Szakács et al.

NATURE REVIEWS DRUG DISCOVERY (2006)

Article Oncology

Phase II trial of dolastatin-10 in patients with advanced breast cancer

EA Perez et al.

INVESTIGATIONAL NEW DRUGS (2005)

Review Plant Sciences

Marine natural products and related compounds in clinical and advanced preclinical trials

DJ Newman et al.

JOURNAL OF NATURAL PRODUCTS (2004)

Review Pharmacology & Pharmacy

Drugs from the deep: marine natural products as drug candidates

B Haefner

DRUG DISCOVERY TODAY (2003)

Article Chemistry, Organic

Synthesis of ecteinascidin ET-743 and phthalascidin Pt-650 from cyanosafracin B

C Cuevas et al.

ORGANIC LETTERS (2000)